Xinyu (Tom) Huang
COO & Head of CMC @ Epigenic Therapeutics
China
Pudong
Biotechnology
Chemistry, NMR, Polymers, Organic Chemistry, HPLC, Chromatography, Analytical Chemistry, UV/Vis, Spectroscopy, LC-MS, Characterization, Mass Spectrometry, Materials Science, IR, Drug Discovery, Formulation, Plastic Extrusion
Experience

CTO
Geneleap Biotech LLC
Boston & Nanjing
Lead Geneleap's R&D activities and global R&D strategies. Oversee Geneleap's daily operations in US and China.

Interim COO
Geneleap Biotech LLC
Nanjing, Jiangsu, China & Boston, Massachusetts, United States
Lead Geneleap's R&D activities and global R&D strategies. Oversee Geneleap's daily operations in US and China. Geneleap Biotech is a biotech company focusing on novel nucleic acid therapeutics to treat infectious diseases and cancer. As a subsidiary company of Luye Pharma, Geneleap has R&D centers in Boston and Nanjing. A GMP pilot plant has also been established and fully operational in the Nanjing site.

Vice President
Boston, Massachusetts, United States and Beijing, China
Built Luye's Boston R&D team and led the development of novel drug delivery technologies, including liposome, microsphere, LNP, drug-device combination and etc. Led Luye's Beijing R&D center on generic oral solid drug product development.
Xinyu (Tom) Huang's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles

Find Emails
Access verified email addresses for your target contacts.
657M+ emails

Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers

More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.











